{"id":"https://openalex.org/W7034426430","doi":null,"title":"Targeting Myeloid Derived Suppressor Cells enhances the response of immune checkpoint inhibitor","display_name":"Targeting Myeloid Derived Suppressor Cells enhances the response of immune checkpoint inhibitor","alternate_titles":[],"publication_year":2017,"publication_date":"2017-05-01","ids":{"openalex":"https://openalex.org/W7034426430"},"language":"en","primary_location":{"id":"pmh:oai:kb.osu.edu:1811/102492","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1811/102492","pdf_url":null,"source":{"id":"https://openalex.org/S4306402304","display_name":"The Knowledge Bank (The Ohio State University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I52357470","host_organization_name":"The Ohio State University","host_organization_lineage":["https://openalex.org/I52357470"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},"parent_works":[],"lineage":["https://openalex.org/W7034426430"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/1811/102492","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071773935","display_name":"David Abood","orcid":"https://orcid.org/0009-0007-0163-2391","observed_orcids":["https://orcid.org/0009-0007-0163-2391"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Abood, David","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5071773935"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7490000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7490000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.24160000681877136,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9800000190734863},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9480000138282776},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.8730000257492065},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.902999997138977},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8500000238418579},{"id":"https://openalex.org/keywords/b16f1-melanoma-cells","display_name":"B16F1 melanoma cells","score":0.8690000176429749},{"id":"https://openalex.org/keywords/bruton-s-tyrosine-kinase-inhibition","display_name":"Bruton's tyrosine kinase inhibition","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.7239999771118164},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8009999990463257},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.8199999928474426},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6758999824523926},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.5943999886512756},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5896999835968018},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.48240000009536743},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.48069998621940613},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4537999927997589},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.450300008058548},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.44429999589920044},{"id":"https://openalex.org/C55721878","wikidata":"https://www.wikidata.org/wiki/Q15220362","display_name":"Myeloid-derived Suppressor Cell","level":4,"score":0.4334999918937683},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43050000071525574},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4300000071525574},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.39480000734329224},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39469999074935913},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38929998874664307},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.3772999942302704},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3626999855041504},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.36149999499320984},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.3513999879360199},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.3409000039100647},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.33469998836517334},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.32760000228881836},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.31779998540878296},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3077999949455261},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.3001999855041504},{"id":"https://openalex.org/C2910954276","wikidata":"https://www.wikidata.org/wiki/Q14912399","display_name":"Fms-Like Tyrosine Kinase 3","level":4,"score":0.2703999876976013},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.2687999904155731},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.26579999923706055},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.26440000534057617},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.26260000467300415},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.2621999979019165},{"id":"https://openalex.org/C32465701","wikidata":"https://www.wikidata.org/wiki/Q14914514","display_name":"Janus kinase 2","level":3,"score":0.25619998574256897},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.25529998540878296},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.25450000166893005}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:kb.osu.edu:1811/102492","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1811/102492","pdf_url":null,"source":{"id":"https://openalex.org/S4306402304","display_name":"The Knowledge Bank (The Ohio State University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I52357470","host_organization_name":"The Ohio State University","host_organization_lineage":["https://openalex.org/I52357470"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"}],"best_oa_location":{"id":"pmh:oai:kb.osu.edu:1811/102492","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1811/102492","pdf_url":null,"source":{"id":"https://openalex.org/S4306402304","display_name":"The Knowledge Bank (The Ohio State University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I52357470","host_organization_name":"The Ohio State University","host_organization_lineage":["https://openalex.org/I52357470"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2276096997","https://openalex.org/W2476363078","https://openalex.org/W4385477422","https://openalex.org/W4243400478","https://openalex.org/W3130638798","https://openalex.org/W3214678228","https://openalex.org/W3032047063","https://openalex.org/W2808333550","https://openalex.org/W3018374911","https://openalex.org/W4404125175"],"abstract_inverted_index":{"Myeloid":[0],"derived":[1],"suppressor":[2],"cells":[3,12],"(MDSC)":[4],"are":[5],"a":[6,31,158,192,195,202,217,228,238,260],"heterogeneous":[7],"population":[8],"of":[9,43,50,56,71,88,120,129,143,155,161,246,268,283],"early":[10],"myeloid":[11],"that":[13,210],"expand":[14],"in":[15,18,82,243,262,270],"tumor-bearing":[16],"hosts":[17],"response":[19,282],"to":[20,41,101,107,132,139,253],"soluble":[21],"factors":[22],"produced":[23],"by":[24,285],"tumor":[25,35,150,221,271],"and":[26,37,59,63,65,76,152,212,249,274],"stromal":[27],"cells.":[28,122,171],"MDSC":[29,156,241,269],"play":[30],"critical":[32],"role":[33],"during":[34],"evasion":[36],"have":[38],"been":[39],"linked":[40],"loss":[42],"immune":[44,103],"effector":[45],"cell":[46,111],"function":[47,119],"through":[48],"variety":[49],"mechanisms":[51],"such":[52],"as":[53],"the":[54,86,118,127,130,141,153,224,244,254,266,280],"generation":[55],"reactive":[57],"oxygen":[58],"nitrogen":[60],"species":[61],"(ROS":[62],"RNS)":[64],"cytokines.":[66],"Ibrutinib,":[67],"an":[68,146],"irreversible":[69],"inhibitor":[70],"Bruton\u2019s":[72],"tyrosine":[73],"kinase":[74,79],"(BTK)":[75],"IL2-inducible":[77],"T-cell":[78],"(ITK),":[80],"is":[81],"clinical":[83],"use":[84],"for":[85,278],"treatment":[87,215,226],"B-cell":[89],"malignancies.":[90],"Tumors":[91,197],"express":[92],"immune-checkpoint":[93],"molecules":[94],"including":[95],"programmed":[96,110],"death":[97,112],"ligand":[98],"1":[99,114],"(PD-L1)":[100],"escape":[102],"destruction.":[104],"PD-L1":[105],"binds":[106],"its":[108,133],"receptor,":[109],"protein":[113],"(PD-1),":[115],"which":[116],"inhibits":[117],"T":[121],"Anti-PD-L1":[123],"monoclonal":[124],"antibody":[125,148,187],"prevents":[126],"engagement":[128],"PDL1":[131],"receptor.":[134],"This":[135],"study":[136],"was":[137],"designed":[138],"investigate":[140],"effect":[142,219],"ibrutinib":[144,178,211,263],"and/or":[145],"anti-PD-L1":[147,184,213,235,284],"on":[149,220],"growth":[151],"levels":[154,267],"using":[157,204],"mouse":[159],"model":[160],"melanoma.":[162],"C57BL/6":[163],"mice":[164],"were":[165,173,198],"inoculated":[166],"with":[167,175,233,287],"1x105":[168],"B16F1":[169],"melanoma":[170],"Mice":[172,231],"treated":[174,232],"either":[176],"vehicle,":[177],"(12.5":[179],"mg/kg)":[180],"via":[181],"drinking":[182],"water,":[183],"(25":[185],"\u00b5g)":[186],"i.p":[188],"injected":[189],"three":[190,200],"times":[191,201],"week,":[193],"or":[194,237],"combination.":[196],"measured":[199],"week":[203],"digital":[205],"calipers.":[206],"Our":[207],"results":[208,258],"show":[209,259],"Ab":[214],"had":[216,227,240],"modest":[218],"growth,":[222],"while":[223],"combination":[225,239,286],"32%":[229],"reduction.":[230],"ibrutinib,":[234],"ab":[236],"level":[242],"spleen":[245],"6.57%,":[247],"5.64%,":[248],"5.46%":[250],"respectively,":[251],"compared":[252],"vehicle\u2019s":[255],"8.58%.":[256],"These":[257],"modulation":[261],"can":[264],"reduce":[265],"bearing":[272],"mice,":[273],"reveals":[275],"potential":[276],"strategy":[277],"enhancing":[279],"anti-tumor":[281],"ibrutinib.":[288]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7034426430","counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}
